Antonella Isacchi Selected Research

Glioma (Gliomas)

1/2015

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonella Isacchi Research Topics

Disease

34	Neoplasms (Cancer) 11/2020 - 07/2005
5	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 12/2014
3	Carcinogenesis 11/2016 - 04/2010
3	Neoplasm Metastasis (Metastasis) 01/2016 - 07/2013
3	Melanoma (Melanoma, Malignant) 01/2016 - 07/2013
2	Chordoma 01/2018 - 01/2017
2	Brain Neoplasms (Brain Tumor) 04/2016 - 07/2013
2	Hematologic Neoplasms (Hematological Malignancy) 04/2012 - 09/2007
2	Carcinoma (Carcinomatosis) 08/2009 - 03/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 05/2015
1	Glioma (Gliomas) 01/2015
1	Genetic Translocation (Chromosomal Translocation) 12/2014
1	Disease Progression 07/2013
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2012
1	Aneuploidy (Aneuploid) 12/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2010
1	Leukemia 08/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2007
1	Inflammation (Inflammations) 10/2004

Drug/Important Bio-Agent (IBA)

18	Phosphotransferases (Kinase)IBA 11/2020 - 10/2004
9	Pharmaceutical PreparationsIBA 01/2017 - 07/2005
7	Proteins (Proteins, Gene)FDA Link 08/2017 - 02/2012
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2010
4	entrectinibIBA 04/2016 - 12/2015
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 04/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2017
2	Brachyury protein (Brachyury)IBA 01/2018 - 01/2017
2	Polo-Like Kinase 1IBA 01/2018 - 04/2012
2	Anaplastic Lymphoma KinaseIBA 04/2016 - 12/2015
2	CrizotinibIBA 04/2016 - 01/2016
2	TropomyosinIBA 01/2016 - 08/2010
2	Calcibiotic Root Canal SealerIBA 01/2016 - 12/2015
2	Adenosine Triphosphatases (ATPase)IBA 09/2013 - 02/2012
2	Biological ProductsIBA 03/2013 - 02/2012
2	danusertibIBA 02/2012 - 09/2007
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2010 - 05/2010
2	Aurora KinasesIBA 04/2010 - 09/2007
1	olaparibIBA 04/2019
1	niraparibIBA 04/2019
1	talazoparibIBA 04/2019
1	rucaparibIBA 04/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	AfatinibIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 09/2016
1	alectinibIBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	ceritinibIBA 01/2016
1	IsoindolesIBA 09/2015
1	PyrrolesIBA 05/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2015
1	Dihydrotachysterol (AT 10)IBA 02/2015
1	Mitogen-Activated Protein KinasesIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2014
1	compound 18IBA 11/2013
1	NMS-873IBA 09/2013
1	NMS-E973IBA 07/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2012
1	NMS P937IBA 04/2012
1	N- (2,6- diethylphenyl)- 1- methyl- 8- ((4- ((1- methylpiperidin- 4- yl)carbamoyl)- 2- (trifluoromethoxy)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamideIBA 12/2010
1	Small Interfering RNA (siRNA)IBA 10/2010
1	rho-Associated KinasesIBA 08/2010
1	fasudil (AT 877)IBA 08/2010
1	N,1,4,4- tetramethyl- 8- ((4- (4- methylpiperazin- 1- yl)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamideIBA 08/2010
1	CarcinogensIBA 08/2010
1	Retinoblastoma ProteinIBA 08/2010
1	N- (6,6- dimethyl- 5- ((1- methylpiperidin- 4- yl)carbonyl)- 1,4,5,6- tetrahydropyrrolo(3,4- c)pyrazol- 3- yl)- 3- methylbutanamideIBA 05/2010
1	EnzymesIBA 04/2010
1	Antineoplastic Agents (Antineoplastics)IBA 03/2010
1	PHA 767491IBA 06/2008
1	Imatinib Mesylate (Gleevec)FDA Link 09/2007
1	Proto-Oncogene Proteins c-metIBA 11/2005

Therapy/Procedure

12	Therapeutics 01/2018 - 09/2007
3	Oral Administration 01/2016 - 08/2010
1	Aftercare (After-Treatment) 03/2007